AbbVie (ABBV)
NYSE:ABBV
Want to see ABBV full AI Analyst Report?
Total Valuation
AbbVie has a market cap or net worth of $355.43B. The enterprise value is $419.13B.
Market Cap$355.43B
Enterprise Value$419.13B
Share Statistics
AbbVie has 1,768,762,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,768,762,300
Owned by Insiders0.06%
Owned by Institutions0.33%
Financial Efficiency
AbbVie’s return on equity (ROE) is -1.29 and return on invested capital (ROIC) is 12.97%.
Return on Equity (ROE)-1.29
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)12.97%
Return on Capital Employed (ROCE)0.22
Revenue Per Employee1.11M
Profits Per Employee76.84K
Employee Count55,000
Asset Turnover0.46
Inventory Turnover3.68
Valuation Ratios
The current PE Ratio of AbbVie is 96.3. AbbVie’s PEG ratio is -77.01.
PE Ratio96.3
PS Ratio6.65
PB Ratio-124.40
Price to Fair Value-124.40
Price to FCF22.83
Price to Operating Cash Flow18.84
PEG Ratio-77.01
Income Statement
In the last 12 months, AbbVie had revenue of 61.16B and earned 4.23B in profits. Earnings per share was 2.37.
Revenue61.16B
Gross Profit42.96B
Operating Income20.09B
Pretax Income6.60B
Net Income4.23B
EBITDA17.63B
Earnings Per Share (EPS)2.37
Cash Flow
In the last 12 months, operating cash flow was 19.03B and capital expenditures -329.00M, giving a free cash flow of 18.70B billion.
Operating Cash Flow19.03B
Free Cash Flow18.70B
Free Cash Flow per Share10.57
Dividends & Yields
AbbVie pays an annual dividend of $1.73, resulting in a dividend yield of 2.87%
Dividend Per Share$1.73
Dividend Yield2.87%
Payout Ratio69.42%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.21
52-Week Price Change15.04%
50-Day Moving Average217.40
200-Day Moving Average213.79
Relative Strength Index (RSI)45.57
Average Volume (3m)6.81M
Important Dates
AbbVie upcoming earnings date is Apr 29, 2026, Before Open (Confirmed).
Last Earnings DateFeb 4, 2026
Next Earnings DateApr 29, 2026
Ex-Dividend Date―
Financial Position
AbbVie as a current ratio of 0.67, with Debt / Equity ratio of -2106.24%
Current Ratio0.67
Quick Ratio0.56
Debt to Market Cap0.17
Net Debt to EBITDA3.62
Interest Coverage Ratio6.94
Taxes
In the past 12 months, AbbVie has paid 2.36B in taxes.
Income Tax2.36B
Effective Tax Rate0.36
Enterprise Valuation
AbbVie EV to EBITDA ratio is 26.70, with an EV/FCF ratio of 26.42.
EV to Sales7.70
EV to EBITDA26.70
EV to Free Cash Flow26.42
EV to Operating Cash Flow24.73
Balance Sheet
AbbVie has $5.26B in cash and marketable securities with $68.87B in debt, giving a net cash position of -$63.62B billion.
Cash & Marketable Securities$5.26B
Total Debt$68.87B
Net Cash-$63.62B
Net Cash Per Share-$35.97
Tangible Book Value Per Share-$51.40
Margins
Gross margin is 70.24%, with operating margin of 32.85%, and net profit margin of 6.91%.
Gross Margin70.24%
Operating Margin32.85%
Pretax Margin10.79%
Net Profit Margin6.91%
EBITDA Margin28.82%
EBIT Margin15.52%
Analyst Forecast
The average price target for AbbVie is $252.95, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$252.95
Price Target Upside21.39% Upside
Analyst ConsensusModerate Buy
Analyst Count22
Revenue Growth Forecast7.40%
EPS Growth Forecast-53.78%